George John Yuri Broze
#161,169
Most Influential Person Now
George John Yuri Broze's AcademicInfluence.com Rankings
George John Yuri Brozephilosophy Degrees
Philosophy
#9301
World Rank
#12839
Historical Rank
Logic
#6285
World Rank
#7791
Historical Rank
Download Badge
Philosophy
George John Yuri Broze's Degrees
- Bachelors Biology University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
- PhD Biomedical Sciences Stanford University
Similar Degrees You Can Earn
Why Is George John Yuri Broze Influential?
(Suggest an Edit or Addition)George John Yuri Broze's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Absence of thrombosis in subjects with heterozygous protein C deficiency. (1987) (560)
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor (1989) (488)
- Regulation of coagulation by a multivalent Kunitz-type inhibitor. (1990) (380)
- The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action (1988) (362)
- Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. (1990) (314)
- Tissue factor pathway inhibitor and the revised theory of coagulation. (1995) (299)
- Targeted disruption of the murine tissue factor gene results in embryonic lethality. (1996) (266)
- Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. (1997) (255)
- Tissue Factor Pathway Inhibitor (1995) (230)
- Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor* (1998) (221)
- Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. (1989) (218)
- Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. (1996) (218)
- Purification and properties of human coagulation factor VII. (1980) (215)
- The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. (1988) (200)
- Human tissue factor: cDNA sequence and chromosome localization of the gene. (1987) (192)
- Tissue factor pathway inhibitor and the current concept of blood coagulation (1995) (176)
- Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. (1989) (175)
- Prothrombotic phenotype of protein Z deficiency. (2000) (173)
- Characterization of the protein Z-dependent protease inhibitor. (2000) (172)
- Protein Z-Dependent Regulation of Coagulation (2001) (170)
- The role of tissue factor pathway inhibitor in a revised coagulation cascade. (1992) (169)
- Binding of human factor VII and VIIa to monocytes. (1982) (163)
- Deficiency of Tissue Factor Pathway Inhibitor Promotes Atherosclerosis and Thrombosis in Mice (2001) (158)
- Characterization of the inhibition of tissue factor in serum. (1987) (148)
- Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor (1988) (145)
- Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. (2002) (144)
- The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. (1980) (144)
- Tissue factor pathway inhibitor: structure-function. (2012) (143)
- A murine model of factor XI deficiency. (1997) (143)
- Isolation of a protein Z-dependent plasma protease inhibitor. (1998) (139)
- Heterogeneity of plasma tissue factor pathway inhibitor. (1994) (139)
- Human Protein Z. (1984) (136)
- Beta protein C is not glycosylated at asparagine 329. The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites. (1990) (133)
- Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. (1987) (132)
- Purification of human brain tissue factor. (1985) (118)
- Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. (1988) (116)
- Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. (1987) (113)
- Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. (1993) (108)
- The protein Z-dependent protease inhibitor is a serpin. (1999) (108)
- Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor (2003) (107)
- The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. (1994) (107)
- A Tail Vein Bleeding Time Model and Delayed Bleeding in Hemophiliac Mice (2001) (102)
- Protein Z Circulates in Plasma in a Complex with Protein Z-Dependent Protease Inhibitor (2001) (99)
- Effect of tissue factor deficiency on mouse and tumor development. (1997) (97)
- Contribution of Host-Derived Tissue Factor to Tumor Neovascularization (2008) (96)
- Tissue factor pathway inhibitor. (1995) (85)
- The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition. (2010) (83)
- Lethal Perinatal Thrombosis in Mice Resulting From the Interaction of Tissue Factor Pathway Inhibitor Deficiency and Factor V Leiden (2002) (82)
- Two Receptor Systems Are Involved in the Plasma Clearance of Tissue Factor Pathway Inhibitor in Vivo(*) (1995) (79)
- [18] Purification of human coagulation factors II, IX, and X using sulfated dextran beads (1981) (78)
- Expression of factor V by resident macrophages boosts host defense in the peritoneal cavity (2019) (76)
- The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo. (1995) (73)
- Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. (1990) (71)
- Protein Z and protein Z-dependent protease inhibitor (2005) (71)
- Formation of Factors IXa and Xa by the Extrinsic Pathway (2004) (70)
- Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2. (1991) (70)
- Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa–tissue factor (2008) (69)
- Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP) (2005) (68)
- Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. (1993) (67)
- Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. (1997) (67)
- A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis (2010) (65)
- Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors. (1998) (64)
- Role of Heparan Sulfate Proteoglycans in the Uptake and Degradation of Tissue Factor Pathway Inhibitor-Coagulation Factor Xa Complexes* (1997) (63)
- Transitions to chaos in a forced jet: intermittency, tangent bifurcations and hysteresis (1996) (62)
- Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein. (1990) (62)
- Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit. (1999) (56)
- The current status of coagulation. (1995) (56)
- The asparagine-linked oligosaccharides on tissue factor pathway inhibitor terminate with SO4-4GalNAc beta 1, 4GlcNAc beta 1,2 Mana alpha. (1992) (54)
- Nonlinear dynamics of forced transitional jets: periodic and chaotic attractors (1994) (54)
- Role for the Kunitz-3 Domain of Tissue Factor Pathway Inhibitor-&agr; in Cell Surface Binding (2004) (52)
- Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency. (2008) (52)
- TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes. (2012) (51)
- Kinetic Characterization of the Protein Z-dependent Protease Inhibitor Reaction with Blood Coagulation Factor Xa* (2008) (49)
- The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. (2007) (48)
- The Low Density Lipoprotein Receptor-related Protein Can Function Independently from Heparan Sulfate Proteoglycans in Tissue Factor Pathway Inhibitor Endocytosis* (1996) (48)
- Heparin Is a Major Activator of the Anticoagulant Serpin, Protein Z-dependent Protease Inhibitor* (2011) (48)
- Novel Organic Solids Deposition and Control Device for Live-Oils: Design and Applications (2006) (48)
- Comparison of cell‐surface TFPIα and β (2005) (47)
- The Role of Factor XI in Coagulation (1993) (45)
- Factor VII–Activating Protease Promotes the Proteolysis and Inhibition of Tissue Factor Pathway Inhibitor (2012) (44)
- Human coagulation factor Va is a cofactor for the activation of protein C. (1983) (44)
- Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. (1989) (44)
- Characterization of platelet-releasable forms of beta-amyloid precursor proteins: the effect of thrombin. (1992) (43)
- The lipoprotein-associated coagulation inhibitor. (1991) (38)
- Inhibition of factor VIIa/tissue factor by antithrombin III and tissue factor pathway inhibitor. (1993) (38)
- Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II. (2011) (37)
- Targeted disruption of the murine tissue factor gene results in embryonic lethality (1996) (37)
- Tissue factor pathway inhibitor and the revised hypothesis of blood coagulation. (1992) (35)
- Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis. (2006) (35)
- Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat. (1999) (33)
- Isolation of the lipoprotein associated coagulation inhibitor produced by HepG2 (human hepatoma) cells using bovine factor Xa affinity chromatography. (1987) (33)
- [19] Human factor VII (1981) (32)
- Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII. (1985) (32)
- Lipoprotein-associated coagulation inhibitor. (1991) (32)
- Human fibroblast tissue factor is inhibited by lipoprotein-associated coagulation inhibitor and placental anticoagulant protein but not by apolipoprotein A-II. (1989) (31)
- Protein-Z and thrombosis (2001) (30)
- The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. (1984) (30)
- Evolution of human von Willebrand factor: cDNA sequence polymorphisms, repeated domains, and relationship to von Willebrand antigen II. (1987) (28)
- Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein Z. (2012) (27)
- Tissue factor pathway inhibitor gene disruption. (1998) (25)
- Comparison of Recombinant Tissue Factor Pathway Inhibitors Expressed in Human SK Hepatoma, Mouse C127, Baby Hamster Kidney, and Chinese Hamster Ovary Cells (1992) (25)
- The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin. (1983) (24)
- Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2. (1990) (23)
- Why do hemophiliacs bleed? (1992) (23)
- Consequences of Tissue Factor Pathway Inhibitor Gene-Disruption in Mice (1997) (22)
- Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder. (2013) (21)
- Lipoprotein Associated Coagulation Inhibitor, Factor VII, Antithrombin III, and Monocyte Tissue Factor Following Surgery (1991) (21)
- Thrombin‐dependent inhibition of fibrinolysis (1996) (18)
- Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice. (2002) (18)
- Effects of glycosaminoglycans on factor XI activation by thrombin. (1993) (17)
- Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo. (2000) (16)
- Revised DNA sequence of exon 1 and 5' flanking region of the human tissue factor pathway inhibitor gene. (1993) (16)
- Contribution of Protein Z and Protein Z-Dependent Protease Inhibitor in Generalized Shwartzman Reaction (2013) (15)
- Substitution of the Gla Domain in Factor X with That of Protein C Impairs Its Interaction with Factor VIIa/Tissue Factor (2007) (14)
- By-Pass Pigging Without or With Speed Control for Gas-Condensate Pipelines (2015) (13)
- The first epidermal growth factor‐like domains of factor Xa and factor IXa are important for the activation of the factor VII–tissue factor complex (2005) (13)
- Utilization of a continuous flow reactor to study the lipoprotein- associated coagulation inhibitor (LACI) that inhibits tissue factor (1990) (13)
- An acquired, calcium-dependent, factor X inhibitor. (2014) (12)
- The Importance of Asphaltene Deposition Measurements in the Design and Operation of Subsea Pipelines (2009) (12)
- cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor. (1990) (12)
- Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy (1987) (11)
- Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy (1987) (11)
- Complementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third Kunitz domains. (1994) (10)
- Dysfunctional endogenous FIX impairs prophylaxis in a mouse hemophilia B model. (2019) (10)
- Antibodies to tissue factor pathway inhibitor are uncommonly detected in patients with infection‐related antiphospholipid antibodies (2003) (8)
- Endothelial injury, coagulation, and atherosclerosis (1991) (7)
- Protein Z and protein Z-dependent protease inhibitor and renal tubules (2009) (7)
- Mouse Protein Z-Dependent Protease Inhibitor cDNA (2001) (7)
- Tissue factor pathway inhibitor endocytosis. (1997) (7)
- A Contraflow Tetherless Mechanical Pipeline Crawler (2003) (5)
- Measuring spatial coupling in inhomogeneous dynamical systems (1997) (5)
- Flow-through tests advance researchers' understanding of asphaltene deposition (2010) (4)
- Animacy, Anthropomimesis, and Musical Line (2013) (3)
- The Asparagine-linked Oligosaccharides on Tissue Factor Pathway Inhibitor Terminate with S 044 GalNAc ~ l , 4 GlcNAc ~ l , 2 Man ~ * (2001) (3)
- cDNA sequence of rabbit tissue factor pathway inhibitor. (1992) (3)
- Expression of Protein Z (PZ) and Protein Z-Dependent Protease Inhibitor (ZPI) In Situ in Human Malignant Tissues. (2005) (3)
- The interaction between LACI and heparin. (1992) (2)
- Nonlinear Dynamics of Forced Transitional Jets: Temporal Attractors and Transitions to Chaos (1994) (2)
- 118 PROTEIN Z DEPENDENT PROTEASE INHIBITOR (ZPI) AND PROTEIN Z IN PERIPHERAL ARTERIAL DISEASE PATIENTS (2008) (2)
- Expression of Protein Z-Dependent Protease Inhibitor (ZPI) In Situ in Different Malignant Tumors. (2004) (2)
- Cold Finger Benchmarking Study for Paraffin Inhibitor Selection (2018) (1)
- Comparison of the Structure, Binding, and Activity of Cell Surface TFPIα and TFPIβ. (2004) (1)
- Improved Coagulation in Bleeding Disorders by NASP Treatment. (2005) (1)
- Fg12 Prothrombinase Activity? (2002) (1)
- “New” Coagulation Inhibitors (1990) (0)
- Expression of recombinant tissue factor pathway inhibitor in an insect cell system (2006) (0)
- Technical Feasibility Study of Advanced Tomography Sensor for Inspection in Piggable Flowlines (2017) (0)
- Current opinion in hematology: Editorial introductions (2008) (0)
- [117] PROTEIN Z LEVELS AND VASCULAR THROMBOTIC DISEASES? A META-ANALYSIS (2009) (0)
- Hemostasis and thrombosis: Editorial review (1995) (0)
- Autoantibodies to TFPI are associated with definite APS but not with infection-related aPL (2003) (0)
- The Tissue Factor Pathway Inhibitor Gamma Knockout Mouse Is a Better Model Than the Wild Type Mouse for Studying Tissue Factor-Related Human Diseases (2019) (0)
- Monoclonal Anti-human Factor (2013) (0)
- Human coagulation factor Va is a c protein C (blood clotting/factor V/clotting inhibitors) (2016) (0)
- Erratum: (Journal of Thrombosis and Haemostasis)) (2009) (0)
- Instability of ZPI Complexes with Factors Xa and (2018) (0)
- Purification and Properties of Heparin-Releasable Lipoprotein-Associated Coagula tion Inhibitor (0)
- Megakaryocyte hyperproliferation without GATA1 mutation in foetal liver of a case of Down syndrome with hydrops foetalis (2008) (0)
- Thrombin-Releasable Protein Z-Dependent Protease Inhibitor Identified in Platelets and Is Likely Due to Uptake from Plasma. (2007) (0)
- Protein hybridizes laci-factor x. (1991) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With George John Yuri Broze?
George John Yuri Broze is affiliated with the following schools:
